Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,631.00
    -1,500.84 (-2.99%)
     
  • CMC Crypto 200

    1,259.40
    -98.61 (-7.26%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Ex-sleuths sue GlaxoSmithKline over imprisonment in China

LONDON, Nov 16 (Reuters) - Two former corporate investigators have sued GlaxoSmithKline (Other OTC: GLAXF - news) , alleging the drugmaker misled them and induced them to investigate an innocent person, resulting in their imprisonment.

The complaint, filed with the U.S. District Court in Philadelphia and made public on Wednesday, was brought by Peter Humphrey, who is British, and his American wife, Yu Yingzeng.

The couple were detained in 2013 and found guilty by a Chinese court in 2014 after being asked by GSK to investigate a whistleblower within the pharmaceuticals group.

They were convicted of illegally obtaining private records of Chinese citizens.

ADVERTISEMENT

The couple allege GSK misled them by stating that the whistleblower's allegations of widespread corruption within the company were false. GSK was fined a record 3 billion yuan ($436 million) in 2014 for paying bribes to doctors to use its drugs.

A GSK spokesman said: "We do not believe this case has any merit and will vigorously defend against the allegations." ($1 = 6.8770 Chinese yuan renminbi) (Reporting by Ben Hirschler and Jonathan Stempel; Editing by Alexander Smith)